Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes.
Nuransoy Cengiz A, Cengiz M, Bozkurt O, Erturk Zararsiz G, Erakcioglu A, Vicdanli SS, Yenisekerci Kulak E, Disli AK, Inanc M, Ozkan M
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.